Distribution of iron in the brain varies with region, cell type, and age. Furthermore, some neurological diseases are accompanied by an abnormal accumulation of iron in specific areas of the CNS. These findings implicate a mobile intracerebral iron pool; however, transport of iron across the blood‐brain barrier and its regulation are largely unknown. In an extensive series of experiments in primary cultures of porcine blood‐brain barrier endothelial cells, we separately quantified surface‐bound and total cellular transferrin receptor pools. Although 90% of all transferrin receptors were located inside the cell, only 10% of these intracellular receptors actively took part in the endocytic cycle. This large “inactive” intracellular transferrin receptor pool could either function as a storage site for spare receptors or be activated by the cell to increase its capacity for iron transport. Data were corrected for nonspecific binding by a separate biochemical assessment using a 100‐fold excess of unlabeled ligand. Data were also analyzed in a nonlinear curve‐fit program. This resulted in a less elaborate and less biased estimate of nonspecific binding.
Iron is essential in the cellular metabolism of all mammalian tissues, including the brain. Intracerebral iron concentrations vary with age and in several (neurological) diseases. Although it is evident that endothelial cells lining the capillaries in the brain are of importance, factors governing the regulation of intracerebral iron concentration are unknown. To investigate the role of blood‐brain barrier endothelial cells in cerebral iron regulation, primary cultures of porcine blood‐brain barrier endothelial cells were grown in either iron‐enriched or iron‐depleted medium. Iron‐enriched cells showed a reduction in surface‐bound and total transferrin receptor numbers compared with iron‐depleted cells. Transferrin receptor kinetics showed that the transferrin receptor internalization rate in iron‐enriched cultures was higher, whereas the transferrin receptor externalization rate in iron‐enriched cultures was lower than the rate in iron‐depleted cultures. Moreover, blood‐brain barrier endothelial cells cultured in iron‐enriched medium were able to accumulate more iron intracellularly, which underlines our kinetic data on transferrin receptors. Our results agree with histopathological studies on brain tissue of patients with hemochromatosis, suggesting that at high peripheral iron concentrations, the rate of iron transport across the blood‐brain barrier endothelial cells is to some extent proportional to the peripheral iron concentration.
Recombinant human transferrin as well as N- and C-terminal half-transferrins, produced in Escherichia coli, are deposited in inclusion bodies by the bacteria. The isolation and purification of the recombinant proteins from these inclusion bodies are described here. The amino acid compositions and N-terminal sequences of the proteins were determined, and found to be in agreement with the known protein structure of human serum transferrin. Renaturation of the recombinant proteins is described, resulting in water-soluble iron-binding molecules. Iron binding was confirmed by 59Fe labelling, absorption spectrophotometry and EPR spectrometry.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.